Global Call to Action: Maximize the public health impact of intermittent preventive treatment of malaria in pregnancy in sub-Saharan Africa

Malaria Journal

Volumn 14, Issue 1, 2015, Pages

  Chico, R Matthew ^a   Dellicour, Stephanie ^b   Roman, Elaine ^c   Mangiaterra, Viviana ^d   Coleman, Jane ^c   Menendez, Clara ^e   Majeres Lugand, Maud ^f   Webster, Jayne ^a   Hill, Jenny ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c JHPIEGO   (United States)

^d TUBERCULOSIS AND MALARIA   (Switzerland)

^e UNIVERSITY OF BARCELONA   (Spain)

^f Access and Product Management Medicine for Malaria Venture   (Switzerland)

Author keywords

Intermittent preventive treatment; Malaria; Pregnant women; Prevention; Sub Saharan Africa

Indexed keywords

PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT;

AFRICA SOUTH OF THE SAHARA; ARTICLE; BED NET; CHILD HEALTH; COMMUNITY INTEGRATION; DRUG INDUSTRY; DRUG INTERMITTENT THERAPY; ENDEMIC DISEASE; HEALTH CARE ACCESS; HEALTH CARE FINANCING; HEALTH CARE POLICY; HELP SEEKING BEHAVIOR; HUMAN; INTEGRATED HEALTH CARE SYSTEM; INTERNATIONAL COOPERATION; MALARIA; MALARIA CONTROL; MATERNAL WELFARE; PREGNANCY; PUBLIC HEALTH SERVICE; REPRODUCTIVE HEALTH; SYSTEMATIC REVIEW (TOPIC); FEMALE; INFANT; NEWBORN; PUBLIC HEALTH; TROPICAL MEDICINE;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALARIA; PREGNANCY; PUBLIC HEALTH; TROPICAL MEDICINE;

EID: 84934936815     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-0728-x     Document Type: Article

References (27)

1. WHO. World malaria report 2014. Geneva: World Health Organization; 2014.
2. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010;7:e1000221.
3. WHO. A strategic framework for malaria prevention and control during pregnancy in the Africa region. Brazzaville: World Health Organization Regional Office for Africa; 2004.
4. Sicuri E, Bardaji A, Nhampossa T, Maixenchs M, Nhacolo A, Nhalungo D, et al. Cost-effectiveness of intermittent preventive treatment of malaria in pregnancy in southern Mozambique. PLoS One. 2010;5:e13407.
5. Radeva-Petrova D, Kayentao K, ter Kuile FO, Sinclair D, Garner P. Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment. Cochrane Database Syst Rev. 2014;10:CD000169.
6. ter Kuile FO, van Eijk AM, Filler SJ. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007;297:2603-16.
7. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, et al. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. JAMA. 2013;309:594-604.
8. van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, et al. Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11. Lancet Infect Dis. 2013;13:1029-42.
9. RBM. The Global Malaria Action Plan. [ http://www.rollbackmalaria.org/about/about-rbm/the-gmap ]
10. RBM. Refined/updated global malaria action plan objectives, targets, milestones and priorities beyond 2011 [ http://www.rollbackmalaria.org/files/files/gmap2011.pdf ]
11. WHO. Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP). Geneva: World Health Organization, Global Malaria Program, Department of Reproductive Health and Research, and Department of Maternal Newborn Child and Adolescent Health; 2013.
12. WHO. Building a Future for Women and Children: The 2012 Report. In: Countdown to 2015: Maternal, Newborn and Child Survival. Geneva: World Health Organization, UNICEF; 2012.
13. Hill J, Kazembe P. Reaching the Abuja target for intermittent preventive treatment of malaria in pregnancy in African women: a review of progress and operational challenges. Trop Med Int Health. 2006;11:409-18.
14. RBM. The Contribution of Malaria Control to Maternal and Newborn Health. In: Progress and Impact Series, Vol. 10. Geneva: Roll Back Malaria Partnership; 2014.
15. Hill J, Hoyt J, van Eijk AM, D'Mello-Guyett L, Ter Kuile FO, Steketee R, et al. Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013;10:e1001488.
16. Simkhada B, Teijlingen ER, Porter M, Simkhada P. Factors affecting the utilization of antenatal care in developing countries: systematic review of the literature. J Adv Nurs. 2008;61:244-60.
17. Agarwal K, Alonso P, Chico RM, Coleman J, Dellicour S, Hill J, et al. Global Call to Action to scale-up coverage of intermittent preventive treatment of malaria in pregnancy: seminar report. Malar J. 2015;14:206, doi:10.1186/s12936-015-0730-3.
18. Consensus Statement. Optimizing the Delivery of Malaria-in-Pregnancy Interventions [ http://sites.path.org/mchn/files/2013/11/MiP-1-V8-Final.pdf ]
19. Gomez PP, Gutman J, Roman E, Dickerson A, Andre ZH, Youll S, et al. Assessment of the consistency of national-level policies and guidelines for malaria in pregnancy in five African countries. Malar J. 2014;13:212.
20. Ouma PO, Van Eijk AM, Hamel MJ, Sikuku E, Odhiambo F, Munguti K, et al. The effect of health care worker training on the use of intermittent preventive treatment for malaria in pregnancy in rural western Kenya. Trop Med Int Health. 2007;12:953-61.
21. Mbonye AK, Bygbjerg I, Magnussen P. Intermittent preventive treatment of malaria in pregnancy: evaluation of a new delivery approach and the policy implications for malaria control in Uganda. Health Policy. 2007;81:228-41.
22. Msyamboza KP, Savage EJ, Kazembe PN, Gies S, Kalanda G, D'Alessandro U, et al. Community-based distribution of sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria during pregnancy improved coverage but reduced antenatal attendance in southern Malawi. Trop Med Int Health. 2009;14:183-9.
23. Ndyomugyenyi R, Tukesiga E, Katamanywa J. Intermittent preventive treatment of malaria in pregnancy (IPTp): participation of community-directed distributors of ivermectin for onchocerciasis improves IPTp access in Ugandan rural communities. Trans R Soc Trop Med Hyg. 2009;103:1221-8.
24. Okeibunor JC, Orji BC, Brieger W, Ishola G, Otolorin E, Rawlins B, et al. Preventing malaria in pregnancy through community-directed interventions: evidence from Akwa Ibom State, Nigeria. Malar J. 2011;10:227.
25. WHO. Policy Brief for the Implementation of Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP) April 2013 (rev. January 2014). Geneva: World Health Organization; 2014.
26. Ouma P, Parise ME, Hamel MJ, Ter Kuile FO, Otieno K, Ayisi JG, et al. A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine. PLoS Clin Trials. 2006;1:e28.
27. Littrell M, Gatakaa H, Evance I, Poyer S, Njogu J, Solomon T, et al. Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries. Malar J. 2011;10:327.